The term muscular dystrophy encompasses a group of genetic diseases characterized by progressive muscle weakness and wasting. There are different types of muscular dystrophy depending on genetic ...

Sickle cell disease (SCD) is an inherited blood disorder marked by defective hemoglobin. It causes red blood cells (RBCs) to deform into a sickle shape, which results in premature death of the RBCs, ...

Clinicians who treat cystic fibrosis can stay up to date on the latest news and perspections about the disease here on RDA's CF Junction.

Paroxysmal nocturnal hemoglobinuria (PNH) is a rare, chronic, life-threatening disorder characterized by the premature breakdown of erythrocytes and the release of hemoglobin into urine for excretion.

A global Delphi panel of physicians and patients has achieved consensus on short- and long-term treatment goals and specific outcome measures for patients with generalized pustular psoriasis (GPP), ...

IgG4-RD can sometimes present with tumor-like features. A male patient in his 8th decade of life presented with upper eyelid and submandibular swelling that were later diagnosed as immunoglobulin-G4 ...

Low-dose rituximab may offer transient efficacy in patients with autoimmune hemolytic anemia (AIHA), including those with cold agglutinin disease (CAD), according to a recent study published in ...

Diffuse large B-cell lymphoma (DLBCL) is a type of cancer that originates in and affects the lymphatic system. 1 It is the most common type of non-Hodgkin lymphoma (NHL), accounting for approximately ...

The novel anti-IL-36 receptor monoclonal antibody recibokibart demonstrated favorable safety and efficacy in treating patients with acute generalized pustular psoriasis (GPP) in a phase 1b study ...

A case of a patient with a rare combination of myelofibrosis (MF) and pyoderma gangrenosum was recently published in the Journal of Cutaneous Immunology and Allergy. “Pyoderma gangrenosum (PG) is a ...

Two phase 3 clinical trials, MOBILIZE and VITALIZE, are recruiting patients with chronic demyelinating polyneuropathy (CIDP) to evaluate the effectiveness of riliprubart according to an abstract ...

Evaluating HDFN Risk With “Confusing” Blood Group Antibodies, Such as Anti-G, Anti-M ...